Sodium oxalate, ACS,99.5%

Sodium oxalate is an orally active dispersant and coordination agent. Sodium oxalate causes mitochondrial dysfunction. Sodium oxalate has catalytic enhancing activity. Sodium oxalate induces stable chronic kidney disease. Sodium oxalate induces highly malignant and undifferentiated breast tumors[1][2][3][4][5][6][7][8].

Product Specifications

CAS Number

[62-76-0]

Product Name Alternative

Ethanedioic acid (sodium), ACS, 99.5%

UNSPSC

12352200

Hazard Statement

H302, H312

Target

Biochemical Assay Reagents; Mitochondrial Metabolism

Type

Biochemical Assay Reagents

Related Pathways

Metabolic Enzyme/Protease; Others

Field of Research

Cancer; Metabolic Disease

Assay Protocol

https://www.medchemexpress.com/sodium-oxalate-acs-99-5.html

Purity

99.65

Solubility

H2O : 5 mg/mL (ultrasonic)

Smiles

O=C(O[Na])C(O[Na])=O

Molecular Formula

C2Na2O4

Molecular Weight

134.00

Precautions

H302, H312

References & Citations

[1]Bai Z, et al. Electrooxidation of formic acid catalyzed by Pd Nanoparticles supported on multi-walled carbon nanotubes with sodium oxalate. Ionics, 2013, 19 (3) : 543-548. |[2]Knoll T, et al. The influence of oxalate on renal epithelial and interstitial cells. Urol Res. 2004 Aug;32 (4) :304-9. |[3]Patel M, et al. Oxalate induces mitochondrial dysfunction and disrupts redox homeostasis in a human monocyte derived cell line. Redox Biol. 2018 May;15:207-215. |[4]Castellaro AM, et al. Oxalate induces breast cancer. BMC Cancer. 2015 Oct 22;15:761. |[5]Heller A, et al. Oxalic acid has an additional, detoxifying function in Sclerotinia sclerotiorum pathogenesis. PLoS One. 2013 Aug 12;8 (8) :e72292. |[6]Flora SJ, et al. Combined administration of oxalic acid, succimer and its analogue for the reversal of gallium arsenide-induced oxidative stress in rats. Arch Toxicol. 2002 Jun;76 (5-6) :269-76. |[7]Mulay SR, et al. Oxalate-induced chronic kidney disease with its uremic and cardiovascular complications in C57BL/6 mice. Am J Physiol Renal Physiol. 2016 Apr 15;310 (8) :F785-F795. |[8]Kamil M A, et al. Pharmacological evaluation of aqueous extract of plant formulation against sodium oxalate induced urolithiasis in mice[J]. Int J Original Res, 2016, 2 (2) : 32-39.